C

China Resources Pharmaceutical Group Ltd
HKEX:3320

Watchlist Manager
China Resources Pharmaceutical Group Ltd
HKEX:3320
Watchlist
Price: 5.18 HKD -2.81% Market Closed
Market Cap: 32.5B HKD
Have any thoughts about
China Resources Pharmaceutical Group Ltd?
Write Note

China Resources Pharmaceutical Group Ltd
Short-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

China Resources Pharmaceutical Group Ltd
Short-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
C
China Resources Pharmaceutical Group Ltd
HKEX:3320
Short-Term Investments
HK$39.7B
CAGR 3-Years
4%
CAGR 5-Years
7%
CAGR 10-Years
N/A
G
Grand Pharmaceutical Group Ltd
HKEX:512
Short-Term Investments
HK$1.6B
CAGR 3-Years
24%
CAGR 5-Years
83%
CAGR 10-Years
N/A
S
SSY Group Ltd
HKEX:2005
Short-Term Investments
HK$41.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
24%
U
United Laboratories International Holdings Ltd
HKEX:3933
Short-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sino Biopharmaceutical Ltd
HKEX:1177
Short-Term Investments
ÂĄ8.7B
CAGR 3-Years
53%
CAGR 5-Years
18%
CAGR 10-Years
32%
H
HUTCHMED (China) Ltd
HKEX:13
Short-Term Investments
$598.5m
CAGR 3-Years
18%
CAGR 5-Years
31%
CAGR 10-Years
N/A
No Stocks Found

China Resources Pharmaceutical Group Ltd
Glance View

Market Cap
32.5B HKD
Industry
Pharmaceuticals

China Resources Pharmaceutical Group Ltd. is an investment holding, which engages in the research and development, manufacture, distribution, and retail of pharmaceutical and healthcare products. The Company, along with its subsidiaries, is principally engaged in the research and development, manufacturing, distribution and retail of pharmaceutical and other healthcare products. The firm mainly operates through three segments. Pharmaceutical Manufacturing segment is engaged in the research and development, manufacturing and sale of pharmaceutical and other healthcare products. Pharmaceutical Distribution segment is engaged in the provision of distribution solutions to pharmaceutical manufacturers and dispensers, such as hospitals and other medical institutions, distributors and retail pharmacies. Pharmaceutical Retail segment is involved in the operation of retail pharmacies in China and Hongkong.

Intrinsic Value
16.46 HKD
Undervaluation 69%
Intrinsic Value
Price
C

See Also

What is China Resources Pharmaceutical Group Ltd's Short-Term Investments?
Short-Term Investments
39.7B HKD

Based on the financial report for Jun 30, 2024, China Resources Pharmaceutical Group Ltd's Short-Term Investments amounts to 39.7B HKD.

What is China Resources Pharmaceutical Group Ltd's Short-Term Investments growth rate?
Short-Term Investments CAGR 5Y
7%

Over the last year, the Short-Term Investments growth was 18%. The average annual Short-Term Investments growth rates for China Resources Pharmaceutical Group Ltd have been 4% over the past three years , 7% over the past five years .

Back to Top